These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29678923)

  • 21. Glucagon-like peptide 1 (GLP-1) as a new therapeutic approach for type 2-diabetes.
    Nauck MA; Holst JJ; Willms B; Schmiegel W
    Exp Clin Endocrinol Diabetes; 1997; 105(4):187-95. PubMed ID: 9285204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved glucose regulation in type 2 diabetic patients with DPP-4 inhibitors: focus on alpha and beta cell function and lipid metabolism.
    Ahrén B; Foley JE
    Diabetologia; 2016 May; 59(5):907-17. PubMed ID: 26894277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications.
    Dunning BE; Gerich JE
    Endocr Rev; 2007 May; 28(3):253-83. PubMed ID: 17409288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternative form of glucose-dependent insulinotropic polypepide and its physiology.
    Fujita Y; Yanagimachi T; Takeda Y; Honjo J; Takiyama Y; Abiko A; Makino Y; Haneda M
    J Diabetes Investig; 2016 Apr; 7 Suppl 1(Suppl 1):33-7. PubMed ID: 27186353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The metabolic effects of chronic hyperglucagonaemia.
    Nankervis A; Proietto J; Ng KW; Alford FP; Larkins R
    Clin Endocrinol (Oxf); 1981 Oct; 15(4):325-33. PubMed ID: 6274544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pancreatic alpha-cell dysfunction in diabetes.
    Burcelin R; Knauf C; Cani PD
    Diabetes Metab; 2008 Feb; 34 Suppl 2():S49-55. PubMed ID: 18640586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose metabolism is altered after loss of L cells and α-cells but not influenced by loss of K cells.
    Pedersen J; Ugleholdt RK; Jørgensen SM; Windeløv JA; Grunddal KV; Schwartz TW; Füchtbauer EM; Poulsen SS; Holst PJ; Holst JJ
    Am J Physiol Endocrinol Metab; 2013 Jan; 304(1):E60-73. PubMed ID: 23115082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes.
    Manell H; Staaf J; Manukyan L; Kristinsson H; Cen J; Stenlid R; Ciba I; Forslund A; Bergsten P
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1181-9. PubMed ID: 26745255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired incretin effect is an early sign of glucose dysmetabolism in nondiabetic patients with psoriasis.
    Gyldenløve M; Vilsbøll T; Zachariae C; Holst JJ; Knop FK; Skov L
    J Intern Med; 2015 Dec; 278(6):660-70. PubMed ID: 26174490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistant maltodextrin promotes fasting glucagon-like peptide-1 secretion and production together with glucose tolerance in rats.
    Hira T; Ikee A; Kishimoto Y; Kanahori S; Hara H
    Br J Nutr; 2015 Jul; 114(1):34-42. PubMed ID: 25671387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Teneligliptin improves glycemic control with the reduction of postprandial insulin requirement in Japanese diabetic patients.
    Tsuchimochi W; Ueno H; Yamashita E; Tsubouchi C; Sakoda H; Nakamura S; Nakazato M
    Endocr J; 2015; 62(1):13-20. PubMed ID: 25252844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of glucagon secretion is lower after oral glucose administration than during intravenous glucose administration in human subjects.
    Meier JJ; Deacon CF; Schmidt WE; Holst JJ; Nauck MA
    Diabetologia; 2007 Apr; 50(4):806-13. PubMed ID: 17334652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inappropriate glucagon response after oral compared with isoglycemic intravenous glucose administration in patients with type 1 diabetes.
    Hare KJ; Vilsbøll T; Holst JJ; Knop FK
    Am J Physiol Endocrinol Metab; 2010 Apr; 298(4):E832-7. PubMed ID: 20103744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute disruption of glucagon secretion or action does not improve glucose tolerance in an insulin-deficient mouse model of diabetes.
    Steenberg VR; Jensen SM; Pedersen J; Madsen AN; Windeløv JA; Holst B; Quistorff B; Poulsen SS; Holst JJ
    Diabetologia; 2016 Feb; 59(2):363-70. PubMed ID: 26537124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced Proglucagon gene expression and L-cell number.
    Patriti A; Aisa MC; Annetti C; Sidoni A; Galli F; Ferri I; Gullà N; Donini A
    Surgery; 2007 Jul; 142(1):74-85. PubMed ID: 17630003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of urea synthesis by diet protein and carbohydrate in normal man and in patients with cirrhosis. Relationship to glucagon and insulin.
    Hamberg O
    Dan Med Bull; 1997 Jun; 44(3):225-41. PubMed ID: 9233544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen deposition.
    Singh V; Grötzinger C; Nowak KW; Zacharias S; Göncz E; Pless G; Sauer IM; Eichhorn I; Pfeiffer-Guglielmi B; Hamprecht B; Wiedenmann B; Plöckinger U; Strowski MZ
    Endocrinology; 2007 Aug; 148(8):3887-99. PubMed ID: 17525126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Native pancreatic alpha-cell adaptation in streptozotocin-induced diabetic primates: importance for pig islet xenotransplantation.
    Dufrane D; Maillart JF; Aouassar N; Goebbels RM; Guiot Y; Gianello P
    Xenotransplantation; 2009; 16(3):152-63. PubMed ID: 19566655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus.
    Knop FK; Vilsbøll T; Madsbad S; Holst JJ; Krarup T
    Diabetologia; 2007 Apr; 50(4):797-805. PubMed ID: 17225124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1.
    Sonne DP; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
    Eur J Endocrinol; 2014 Oct; 171(4):407-19. PubMed ID: 24986531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.